Metrex announces the launch of an all-new ready-to-use surface disinfection product, CaviCide1. CaviCide1 is the only one-step, low-alcohol surface disinfectant offering a 1-minute TB kill claim, materials compatibility plus more than 25 other clinically relevant organism kill claims, including norovirus and Acinetobacter baumannii. The formulation enables CaviCide1 to be both an effective cleaner and an effective disinfectant.
CaviCide1 is the result of years of research and development based off of customer feedback," says Todd Norbe, president of Metrex. "We are extremely excited to enable our customers to do their jobs with greater ease and peace of mind as we continue to work at protecting people within the healthcare environment."
CaviCide1, a multi-purpose disinfectant/decontaminant cleaner, can be used on hard, non-porous surfaces and joins the current family of CaviCide products including CaviCide and CaviWipes. The improvements found in the latest formulation are effective in killing 99.9 percent of bacteria, viruses and fungi in 1 minute including TB, norovirus, A. baumannii, HIV-1, HBV,HCV and many more. When used as directed, the fragrance free CaviCide1 will effectively clean and disinfect surfaces and can help reduce the risk of cross contamination.
CaviCide1 is available in 2-ounce, 8-ounce and 24-ounce sprays, or 1 gallon and 2.5 gallon bottles, and a 55-gallon drum. To receive a sample of CaviCide1, visit www.cavicide1.com.Â
Â
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.